Use of classification regression tree in predicting oral absorption in humans

Journal of Chemical Information and Computer Sciences

Volumn 44, Issue 6, 2004, Pages 2061-2069

  Bai, Jane P F ^a   Utis, Andrey ^b   Crippen, Gordon ^c   He, Han Dan ^d   Fischer, Volker ^d   Tullman, Robert ^d   Yin, He Qun ^d   Hsu, Cheng Pang ^e   Jiang, Lan ^f   Hwang, Kin Kai ^f  

^a ZyxBio LLC   (United States)

^b ZyxBio LLC   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e JOHNSON AND JOHNSON   (United States)

^f SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION REGRESSION TREES (CART); HYDROGEN BOND DONORS (HBD); ORAL ABSORPTION; SILICO METHODS;

AMINO ACIDS; DATA ACQUISITION; DATA MINING; HYDROGEN BONDS; MONOLAYERS; REGRESSION ANALYSIS; STATISTICAL METHODS;

DRUG PRODUCTS;

EID: 10044296378     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci040023n     Document Type: Article

References (35)

1. PhRMA Pharmacuetical Industry Profile 2001 (PhRMA Web site).
2. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Res. 1997, 23, 3.
3. Gao, H.; Shanmugasundaram, V.; Lee, P. Estimation of aqueous solubility of organic compounds with QSPR approach. Pharm. Res. 2002, 19, 497.
4. Zhu, G.; Jiang, L.; Chen, T. M.; Hwang, K. K. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. Eur. J. Med. Chem. 2002, 37, 399.
5. McElroy, N. R.; Jurs, P. C. Prediction of aqueous solubility of heteroatom-containing organic compounds from molecular structure. J. Chem. Inf. Comput. Sci. 2001, 41, 1237.
6. Gillet, V. J.; Willett, P.; Bradshaw, J. Identification of biological activity profiles using substructural analysis and genetic algorithms. J. Chem. Inf. Comput. Sci. 1998, 38, 165.
7. Klopman, G.; Wang, S.; Balthasar, D. M. Estimation of aqueous solubility of organic molecules by the group contribution approach. Application to the study of Biodegradation. J. Chem. Inf. Comput. Sci. 1992, 32, 474.
8. Falconer, J. A.; Naughton, B. J.; Dunlop, D. D.; Roth, E. J.; Strasser, D. C.; Sinacore, J. M. Predicting stroke inpatient rehabilitation outcome using a classification tree approach. Archives Phys. Med. Rehab. 1994, 75, 619.
9. Mair, J.; Smidt, J.; Kecgkeutber, P.; Dienstl, F.; Puschendorf, B. A decision tree for the early diagnosis of acute myocardial infarction in nontraumatic chest pain patients at hospital admission. Chest 1995, 108, 1502.
10. van de Waterbeemd, H.; Smith, D. A.; Beaumont, K.; Walker, D. K. Property-based design: Optimization of drug absorption and pharmacokinetics. J. Med. Chem. 2001, 44, 1313.
11. OraSpotter human pharmacokinetic database. ZyxBio, LLC: Hudson, OH. (www.zyxbio.com).
12. Burton, P. S.; Conradi, R. A.; Hilgers, A. R.; Ho, N. F. H.; Maggiora, L. L. The relationship between peptide structure and transport across epithelial cell monolayers. J, Controlled Release 1992, 19, 87.
13. MOE Molecular Operating Environment software. Chemical Computing Group, Inc.: Vancouver, Canada (www.chemcomp.com).
14. Bai, P.-F.; Amidon, G. L. Gastrointestinal Transport of Peptide and Protein Drugs and Prodrugs. In Pharmacokinetics of Drugs; Welling, P. G., Balant, L. P., Eds.; Springer-Verlag: New York. 1991; pp 189-205.
15. Breiman, L.; Friedman, J. H.; Olshen, R. A.; Stone, C. J. Classification and Regression Trees; Wadsworth: Belmont, 1984.
16. Quinlan, J. R. a. Induction of decision trees. Machine Learning 1986, 1, 81. b. www.cse.unsw.edu.au/quinlan.
17. Quinlan, J. R. a. Induction of decision trees. Machine Learning 1986, 1, 81. b. www.cse.unsw.edu.au/quinlan.
18. Free software of modified CART capable of nonlinear regression from Dr. Wei-Yin Loh of Statistics Department, University of Wisconsin, Madison, Wisconsin.
19. Gros, P.; Talbot, F.; Tang-Wai, D.; Bibi, E.; Kaback, R. Lipophilic cations: A group of model substrates for the multidrug-resistance transport. Biochemistry 1992, 31, 1992.
20. Hidalgo, I. J.; Raeissi, S. D. The role of an alpha-amino group on H+-dependent transepithelial transport of celphalosporins in Caco-2 cells. J. Pharm. Pharmacol. 1999, 51, 35.
21. Sinko, P. J.; Amidon, G. L. Characterizaiton of the oral absorpton of beta-lactam antibiotics. I. Cephalosporins: determination of intrinsic membrane absorption parameters in the rat intestine in situ. Pharm. Res. 1988, 5, 645.
22. Ruiz-Balaguer, N.; Nacher, A.; Casabo, V. G.; Merino Sanjuan, M. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes. Int. J. Pharm. 2002, 234, 101.
23. Friedman, D. L.; Amidon, G. L. Passive and carrier-mediated intestinal absorption components of two angiotensin-converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinpril. Pharm. Res. 1989, 6, 1043.
24. Wildman, S. A.; Crippen, G. M. Prediction of physicochemical parameters by atomic contributions. J. Chem. Inf. Comput. Sci. 1999, 39, 868.
25. Wang, R.; Fu, Y.; Lai, L. A new atom-additive method for calculating partition coefficients. J. Chem. Inf. Comput. Sci. 1997, 37, 615.
26. Ertl, P.; Rohde, B.; Selzer, P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 2000, 43, 3714.
27. Scheiner, S. Hydrogen bonding; Oxford University Press: New York, New York, 1977.
28. March, J. Advanced organic chemistry, 3rd ed.; John Wiley & Sons: New York, 1985.
29. mol2,smi. Daylight Chemical information Inc (www.daylight.com): Mission Viejo, California.
30. Kempf, D. J.; Sham, H. L.; Marsh, K. C.; Flentge, C. A.; Betebenner, D.; Green, B. E.; McDonald, E.; Vasavanonda, S.; Saldivar, A.; Wideburg, N. E.; Kati, W. M.; Ruiz, L.; Zhao, C.; Fino, L.; Patterson, J.; Molla, A.; Plattner, J. J.; Norbeck, D. W. Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy. J. Med. Chem. 1998, 41, 602.
31. Kim, H. J.; Kim S. H.; Kim, S. O.; Lee, D. H.; Lim, H.; Yoo, S. E.; Lee, M. G. Dose-dependent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, in rats. Biopharm. Drug Disp. 2000, 21, 279.
32. Kim, E. J.; Kim, S. O.; Lee, D. H.; Lim, H.; Lee, M. G. Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect. Biopharm. Drug Disp. 2001, 22, 119.
33. Krause, W.; Hampel, M. Pharmacokinetics of proterguride in rat and cynomolgus monkey. Xenobiotica 1988, 18, 41.
34. Patt, W. C.; Edmunds, J. J.; Repine J. T.; Berryman, K. A.; Reisdorph, B. R.; Lee, C.; Plummer, M. S.; Shahripour, A.; Haleen, S. J.; Keiser, J. A.; Flynn, M. A.; Welch, K. M.; Reynolds, E. E.; Rubin, R.; Tobias, B.; Hallak H.; Doherty A. M. Structure relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonists. J. Med. Chem. 1997, 40, 1063.
35. Wu, C.; Chan M. F.; Stavros, F.; Raju, B.; Okun, I.; Mong, S.; Keller, K. M.; Brock, T.; Kogan, T. P., Dixon, R. A. Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist. J. Med. Chem. 1997, 40, 1690.